Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Rebecca S. Finley"'
Autor:
Rebecca S. Finley
Publikováno v:
American Journal of Health-System Pharmacy. 75:1185-1190
As a dean of a college of pharmacy, I spend most of my days considering and tending to what I perceive to be the needs or well-being of our profession’s future—that is, our student pharmacists. As academic and practice leaders, we have an obligat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1592a7e31e08abad2d2ad7a2f9da0049
https://doi.org/10.2146/ajhp180249
https://doi.org/10.2146/ajhp180249
Publikováno v:
American Journal of Health-System Pharmacy. 72:2098-2100
The role of the pharmacist in cancer care has continued to evolve over the last 50 years, in part due to more consistent integration of the pharmacist into cancer care teams. There has been tremendous growth in the number of practitioners who practic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec7cc8f3b9d73e1449ef9db35ccb767
https://doi.org/10.2146/ajhp150637
https://doi.org/10.2146/ajhp150637
Autor:
Rebecca S. Finley
Publikováno v:
American Journal of Health-System Pharmacy. 60:S4-S10
Targeted therapies for cancer are discussed. Research into the molecular biology of cancer has revealed critical differences between normal and tumor cells and has pinpointed key processes that regulate the growth and progression of cancers. This has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a1122a0a4313e83ffc1718ccca1603
https://doi.org/10.1093/ajhp/60.suppl_9.s4
https://doi.org/10.1093/ajhp/60.suppl_9.s4
Publikováno v:
Journal of Pharmacy Teaching. 9:47-60
The Philadelphia College of Pharmacy (PCP) recently transitioned to an entry-level doctor of pharmacy program. To help maintain a high-quality program, assessment of curricular outcomes is necessary. The Planning Committee of the PCP at the Universit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f11b44bdd1abe9b511ecba7c60af11b2
https://doi.org/10.1300/j060v09n02_04
https://doi.org/10.1300/j060v09n02_04
Publikováno v:
American Journal of Health-System Pharmacy. 55:1269-1274
Patterns of antiemetic therapy and its outcomes in patients undergoing high-dose antineoplastic therapy were studied. The study, conducted at a cancer center, included both a retrospective evaluation of patients undergoing highly emetogenic high-dose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59ae212d0c7d9d3942ebddc6ca28ce13
https://doi.org/10.1093/ajhp/55.12.1269
https://doi.org/10.1093/ajhp/55.12.1269
Autor:
Rebecca S. Finley
Publikováno v:
American Journal of Health-System Pharmacy. 53:1813-1816
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e8a1ad5813701bee9c1a9ee8a9a7636
https://doi.org/10.1093/ajhp/53.15.1813
https://doi.org/10.1093/ajhp/53.15.1813
Autor:
Bary W. Brown, Kathryn A. Newman, Jai H. Joshi, Mark Moody, Rebecca S. Finley, Robert L. Ruxer, Stephen C. Schimpff
Publikováno v:
Supportive Care in Cancer. 1:186-194
In a prospective, randomized trial, 205 febrile episodes in granulocytopenic cancer patients were treated with ceftazidime with or without tobramycin (C±T), both agents being administered only if the initial granulocyte count was below 200/μl, or c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14d726b88c2df57b388814f89aed3c13
https://doi.org/10.1007/bf00366445
https://doi.org/10.1007/bf00366445
Autor:
Rebecca S. Finley
Publikováno v:
American Journal of Health-System Pharmacy. 50:765-772
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9929e4a2920e2aebf6e6c832ac6ed1b
https://doi.org/10.1093/ajhp/50.4.765
https://doi.org/10.1093/ajhp/50.4.765
Autor:
Rebecca S. Finley
Publikováno v:
Cancer. 67:2727-2730
The increasing cost of and demand for health care have intensified the concern that some form of health care rationing is inevitable. Cost studies require the identification, measurement, and comparison of all significant positive and negative conseq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62fe402d92e3983aabea432bb385369f
https://doi.org/10.1002/1097-0142(19910515)67:10+<2727::aid-cncr2820671710>3.0.co
https://doi.org/10.1002/1097-0142(19910515)67:10+<2727::aid-cncr2820671710>3.0.co
Autor:
Michele A. Hood, Rebecca S. Finley
Publikováno v:
DICP. 25:518-524
The new fluorinated adenine analog, fludarabine, has been tested for efficacy in many tumor types over the past ten years. Two other similar nucleoside analogs are currently available for commercial use. Cytarabine is used principally as an antileuke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8fc9bc7ed622550ee03831202e6c9b6
https://doi.org/10.1177/106002809102500512
https://doi.org/10.1177/106002809102500512